Determination of median levels of the free β subunit of human chorionic gonadotropin in women from mainland China using a new time-resolved fluoroimmunoassay

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 1, 2010, Pages 109-114

  Tang, Yong Ping ^a   Wu, Ying Song ^a   Yin, Ai Hua ^b   Xu, Wei Wen ^a   Yuan, Peng Hui ^c   Li, Ming ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Guangdong Women and Children Hospital   (China)

^c Guangzhou Darui Antibody Co Ltd   (China)

Author keywords

Down syndrome; Free subunit of human chorionic gonadotropin; Median; Prenatal screening

Indexed keywords

CHELATE; CHORIONIC GONADOTROPIN BETA SUBUNIT; MONOCLONAL ANTIBODY; SAMARIUM;

ARTICLE; CHINA; CONTROLLED STUDY; FEMALE; FLUOROIMMUNOASSAY; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; PREGNANT WOMAN; PRIORITY JOURNAL; TIME;

CHINA; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CROSS REACTIONS; EUROPIUM; FEMALE; FLUOROIMMUNOASSAY; GESTATIONAL AGE; HUMANS; LIMIT OF DETECTION; PREGNANCY; REFERENCE VALUES; TIME FACTORS;

EID: 74549173482     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.005     Document Type: Article

References (23)

1. Dirnhofer S, Madersbacher S, Bidart JM, Ten Kortenaar PB, Spottl G, Mann K, et al. The molecular basis for epitopes on the free beta-subunit of human chorionic gonadotrophin (hCG), its carboxyl-terminal peptide and the hCG beta-core fragment. J Endocrinol 1994;141:153-162
2. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein- A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008;31:493-502.
3. Liao C, Huang Y, Li D, Song S, Yi C, Zhou J. Second-trimester maternal serum screening for Down syndrome in Mainland China. Prenat Diagn 2006;26:1271-1272
4. Cuckle H. Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol 2000;92:97-101.
5. Barken SS, Skibsted L, Jensen LN, Sperling L, Zingenberg H, Brondum-Nielsen K. Diagnosis and prediction of parental origin of triploidies by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11-14 weeks of gestation. Acta Obstet Gynecol Scand 2008;87:975-978
6. Spencer K, Coombes EJ, Mallard AS, Ward AM. Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers. Ann Clin Biochem 1992;29(Pt 5):506-518
7. Hsu JJ, Hsieh TT, Soong YK, Spencer K. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age. Prenat Diagn 1997;17:707-716
8. Wenstrom KD, Owen J, Chu DC, Boots L. Free beta-hCG subunit versus intact hCG in Down syndrome screening. Obstet Gynecol 1997;90:370-374
9. Hsieh TT, Hsu JJ, Cheng PJ, Lee CN, Jou HJ, Chen CP. Total hCG versus free beta-hCG combined with alpha-fetoprotein for Down syndrome screening in Taiwan. Taiwan J Obstet Gynecol 2007;46:230-235
10. Benn PA, Clive JM, Collins R. Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups. Clin Chem 1997;43:333-337
11. Leung TY, Spencer K, Leung TN, Fung TY, Lau TK. Higher median levels of free beta-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population. Fetal Diagn Ther 2006;21:140-143
12. Hemmila I, Dakubu S, Mukkala VM, Siitari H, Lovgren T. Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 1984;137:335-343
13. Macri JN, Spencer K, Anderson RW, Cook EJ. Free beta-chorionic gonadotropin: a cross-reactivity study of two immunometric assays used in prenatal maternal serum screening for Down's syndrome. Ann Clin Biochem 1993;30:94-98
14. Pettersson K, Alfthan H, Stenman UH, Turpeinen U, Suonpaa M, Soderholm J, et al. Simultaneous assay of alpha-fetoprotein and free beta subunit of human chorionic gonadotropin by duallabel time-resolved immunofluorometric assay. Clin Chem 1993;39:2084-2089
15. Fan C, Goto S, Furuhashi Y, Tomoda Y. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease. J Clin Endocrinol Metab 1987;64: 313-318
16. Spencer K. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free betahCG and pregnancy-associated plasma protein-A assays. Ann Clin Biochem 2005;42:30-40.
17. Niemimaa M, Heinonen S, Seppala M, Ryynanen M. The influence of smoking on the pregnancy-associated plasma protein A, free beta human chorionic gonadotrophin and nuchal translucency. Br J Obstet Gynaecol 2003;110:664-667
18. Xie Z, Lu S, Zhu Y, Sun Y, Jin Y. Second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein levels in normal twin and singleton pregnancies: a report of local Chinese population. Prenat Diagn 2008;28: 735-738
19. Linskens IH, Levitus M, Frans A, Schielen PC, van Vugt JM, Blankenstein MA, et al. Performance of free beta-human chorionic gonadotrophin (free beta-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands. Clin Chem Lab Med 2009;47:222-226
20. Zhu L, Leinonen J, Zhang WM, Finne P, Stenman UH. Duallabel immunoassay for simultaneous measurement of prostatespecific antigen (PSA)-alpha1- antichymotrypsin complex together with free or total PSA. Clin Chem 2003;49:97-103.
21. Qin Q, Christiansen M, Lovgren T, Norgaard-Pedersen B, Pettersson K. Dual-label time-resolved immunofluorometric assay for simultaneous determination of pregnancy-associated plasma protein A and free beta-subunit of human chorionic gonadotrophin. J Immunol Methods 1997;205:169-175
22. Krantz DA, Larsen JW, Buchanan PD, Macri JN. First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Am J Obstet Gynecol 1996;174:612-616
23. Spencer K. Evaluation of an assay of the free beta-subunit of choriogonadotropin and its potential value in screening for Down's syndrome. Clin Chem 1991;37:809-814